The development of DENV-specific CD4+ and CD8+ T-lymphocyte responses [34], and the activation and contraction of antiviral CD8+ T lymphocytes in the defervescence and convalescence phases of dengue fever has previously been documented [35]. This evidence concerns the gene CD8A and dengue disease.